Former Novartis chief Daniel Vasella's 2009 bonus will be close to three times the amount he would be due based on relative earnings growth among large cap peers, a study showed on Wednesday.
The report, compiled by UK proxy voting agency Manifest and Swiss consultancy Obermatt, estimated his total at 2009 bonus 6.3 million Swiss francs ($5.96 million).
That would be around 4 million Swiss francs above the maximum level calculated by Obermatt, which bases its bonus recommendation on the number of peers a company outperforms -- the more peers are beaten, the higher the bonus.
The company was not immediately able to confirm the estimated bonus level for 2009.
"Dr Vasella's base as well as total compensation is in line with that of CEOs from other large healthcare companies," a company spokesman said. (Más)
Ver tambien, te interesará seguro...
No hay comentarios:
Publicar un comentario